Historical Ibogaine Media

Ibogaine: the 90s Mahn...

Historical Ibogaine Media & Press Archives This is not a complete archive of ibogaine-related pieces from the 90s, it represents part of a collection of materials which were not accessible on the internet previously. In particular it focuses on the FDA and NIDA’s involvement during a period of time when…

Continue reading

Ibogaine Patents @ the USPO

Ibogaine Patents @ the United States Patent Office (USPO) Use of ibogaine in reducing excitotoxic brain damage Use of ibogaine in reducing excitotoxic brain damage This invention discloses that ibogaine, a plant derivative, can be used as a safe NMDA antagonist at relatively high dosages (including dosages high enough to…

Continue reading

Ibogaine Abstracts on PubMed

18-Methoxycoronaridine (18-MC) and ibogaine: comparison of antiaddictive efficacy, toxicity, and mechanisms of action. 18-Methoxycoronaridine (18-MC) and ibogaine: comparison of antiaddictive efficacy, toxicity, and mechanisms of action. 18-MC, a novel iboga alkaloid congener, is being developed as a potential treatment for multiple forms of drug abuse. Like ibogaine (40 mg/kg), 18-MC…

Continue reading

2009: Drug Policy Alliance Conference

The Drug Policy Alliance 2009 International Conference Albuquerque Convention Center — Albuquerque, New Mexico Saturday, November 14, 2009, 3:00 PM – 4:30 PM Room: Sleta / Jemez Moderator: Howard Lotsof, President, Dora Weiner Foundation, Staten Island, NY Mr. Lotsof is the recipient of this year’s Robert Randall Award for Achievement…

Continue reading

1999: NYU Ibogaine Conference

1999: NYU Ibogaine Conference Original Message ***************** There will be a Conference on Ibogaine at NYU School of Medicine on November 5 & 6, 1999. Perhaps some of you would be interested in attending. You can view the Conference web page, which includes the Conference Program and participants, a review…

Continue reading

Seeking Ways to Crack Cocaine Addiction

Feature: Seeking Ways to Crack Cocaine Addiction The Lancet [Volume 352, Number 9136] 17 October 1998 by Kelly Morris The use of cocaine, a highly addictive stimulant and euphoriant with few physical withdrawal symptoms, is increasing. Up to 10% of ever-users will become heavy users, particularly if they inject the…

Continue reading

Anti-Addiction Drug in Limbo

Illegal in U.S., ibogaine advocates say it blocks withdrawal symptoms By Malcolm Ritter / Associated Press (2000) What if addiction, whether to cocaine, heroin or alcohol, could be broken by taking a single pill? That’s the audacious claim behind ibogaine, an extract of an African shrub. But don’t look for…

Continue reading

Addiction Treatment Strives for Legitimacy

by Brian Vastag Journal of the American Medical Association Vol. 288 No. 24, pp. 3096-3101, December 25, 2002 © 2002 American Medical Association. All rights reserved. Tabernanthe iboga, the West African source of ibogaine, used by some to treat addiction. New York — Some drugs are made in laboratories. Others,…

Continue reading

Sacrament of Transition: Protocol for Ibogaine Initiations

Sacrament of Transition

By Anže Tavčar Copyright © 2007, Anže Tavčar All Rights Reserved 1. What is Sacrament of Transition The Sacrament of Transition is a religious community registered with the Office for Religious Communities of the Republic of Slovenia since 1999 in compliance with all applicable laws. The religion of Sacrament of…

Continue reading

Ibogaine in the Treatment of Chemical Dependence Disorders

Ibogaine in the Treatment of Chemical Dependence Disorders: Clinical Perspectives Copyright © 1994, Howard S. Lotsof All Rights Reserved Reproduced by permission of: The Ibogaine Dossier (Original Publication: MAPS – Volume 5, Number 3, Winter 1994-95) Dedicated to the work of J. Bastiaans and N. Adriaans In memory of N.…

Continue reading